For a Legal Perspective on today's much-anticipated U.S. Supreme Court "Myriad" decision that naturally occuring substances are not patentable, we turned to IP attorneys writing on JD Supra...more
- AMP v Myriad Biotechnology DNA Healthcare Human Genes Legal Perspectives Myriad Patents SCOTUS
The U.S. Supreme Court decided today that claims to isolated genomic DNA are not patentable subject matter and thus invalid. This decision rendered invalid patent claims owned by Myriad Genetics as well as thousands of patent...more
- AMP v Myriad DNA Gene Patenting Human Genes Myriad Patent-Eligible Subject Matter Patents Product of Nature Doctrine SCOTUS
On February 19, 2013, the United States Supreme Court heard oral arguments in Vernon Hugh Bowman v. Monsanto Company. This case has far-reaching implications for the patent exhaustion or first sale doctrine in...more
- Bowman v Monsanto First Sale Doctrine Genetically Engineered Seed Infringement Patent Exhaustion Patents SCOTUS
JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...
Learn More or Schedule a demo